Last reviewed · How we verify

NCT04703231

Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause

Completed Last updated 18 April 2022
What this trial tests

trial testing measurement of macular thickness, corneal thickness and lens opacities in Menopause Surgical in 60 participants. Completed in 23 March 2022.

Timeline
1 September 2020
Primary endpoint
23 March 2022
23 March 2022

Quick facts

Lead sponsorBatman Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date1 September 2020
Primary completion23 March 2022
Estimated completion23 March 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Batman Training and Research Hospital

Who can join

Adults 45 to 65, female only, with Menopause Surgical or Macula Edema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is aimed to compare the ocular findings in patients with natural and surgical menopause.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Batman Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04703231.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing